Glucose Health (GLUC) vs. Its Rivals Critical Contrast

Glucose Health (OTCMKTS:GLUC) is one of 53 publicly-traded companies in the “Medicinals & botanicals” industry, but how does it weigh in compared to its peers? We will compare Glucose Health to related businesses based on the strength of its analyst recommendations, dividends, earnings, institutional ownership, risk, valuation and profitability.

Volatility and Risk

Glucose Health has a beta of 3.49, suggesting that its stock price is 249% more volatile than the S&P 500. Comparatively, Glucose Health’s peers have a beta of 1.20, suggesting that their average stock price is 20% more volatile than the S&P 500.

Profitability

This table compares Glucose Health and its peers’ net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Glucose Health	-75.00%	N/A	N/A
Glucose Health Competitors	-41.35%	-262.15%	-7.81%

Analyst Ratings

This is a summary of current ratings and target prices for Glucose Health and its peers, as provided by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Glucose Health	0	0	0	0	N/A
Glucose Health Competitors	272	555	991	74	2.46

As a group, “Medicinals & botanicals” companies have a potential upside of 50.25%. Given Glucose Health’s peers higher probable upside, analysts clearly believe Glucose Health has less favorable growth aspects than its peers.

Earnings & Valuation

This table compares Glucose Health and its peers revenue, earnings per share and valuation.

	Gross Revenue	Net Income	Price/Earnings Ratio
Glucose Health	$540,000.00	-$420,000.00	-7.00
Glucose Health Competitors	$314.44 million	-$49.81 million	-14.58

Glucose Health’s peers have higher revenue, but lower earnings than Glucose Health. Glucose Health is trading at a higher price-to-earnings ratio than its peers, indicating that it is currently more expensive than other companies in its industry.

Institutional & Insider Ownership

15.8% of shares of all “Medicinals & botanicals” companies are owned by institutional investors. 21.3% of shares of all “Medicinals & botanicals” companies are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.

Summary

Glucose Health peers beat Glucose Health on 5 of the 9 factors compared.

Glucose Health Company Profile

Glucose Health, Inc. engages in the formulation, manufacturing, marketing, and distribution of soluble fiber infused nutritional beverages. It offers soluble fiber infused powdered iced tea, and flavored drink mixes for pre-diabetic and diabetic persons under the GLUCODOWN brand in North America. The company was formerly known as Bio-Solutions Corp. and changed its name to Glucose Health, Inc. in November 2014. Glucose Health, Inc. was incorporated in 2007 and is based in Bentonville, Arkansas.